MACULAR EDEMA SECONDARY TO INFLAMMATION
Clinical trials for MACULAR EDEMA SECONDARY TO INFLAMMATION explained in plain language.
Never miss a new study
Get alerted when new MACULAR EDEMA SECONDARY TO INFLAMMATION trials appear
Sign up with your email to follow new studies for MACULAR EDEMA SECONDARY TO INFLAMMATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye drug aims to restore vision in Inflammation-Related swelling
Disease control Recruiting nowThis phase 3 trial tests an experimental drug called tabirafusp alfa (KSI-101) given as an eye injection for people with macular edema (swelling) caused by inflammation. The study will compare the drug to a sham (fake) injection in 600 participants to see if it improves vision an…
Matched conditions: MACULAR EDEMA SECONDARY TO INFLAMMATION
Phase: PHASE3 • Sponsor: Kodiak Sciences Inc • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New eye drug aims to restore vision in inflammatory swelling
Disease control Recruiting nowThis study tests an experimental drug called tabirafusp alfa (KSI-101) given as an eye injection to treat macular edema (swelling in the back of the eye) caused by inflammation. About 300 adults with vision loss from this condition will receive either the drug or a sham injection…
Matched conditions: MACULAR EDEMA SECONDARY TO INFLAMMATION
Phase: PHASE3 • Sponsor: Kodiak Sciences Inc • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC